Brian A. Leuthner, President and CEO at Edge Therapeutics, Inc. (EDGE), sold 3,000 shares at $9.61 ($28K) on 2017-02-02, disclosed to the SEC on 2017-02-03.
Scheduled sale ($28k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.38 | 1,500 | $14K | 49.4% |
| 2 | $9.61 | 1,500 | $14K | 50.6% |
| Total | $9.49 avg | 3,000 | $28K | 100% |
| Filing → |
| EDGE | SELL | 2018-02-23 | $77K | — | Filing → |
| EDGE | SELL | 2018-02-02 | $65K | — | Filing → |
| EDGE | SELL | 2018-01-03 | $51K | — | Filing → |